Regulation of intestinal and hypothalamic apolipoprotein A-IV

被引:16
|
作者
Liu, M [1 ]
Doi, T [1 ]
Tso, P [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
关键词
apolipoprotein A-IV; lipid; intestine; hypothalamus;
D O I
10.1177/153537020322801013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This review discusses the regulation of the intestinal and hypothalamic apolipoprotein A-IV (apo A-IV) gene and protein expression. Apo A-IV is a glycoprotein secreted together with triglyceride-rich lipoproteins by the small intestine. Intestinal apo A-IV synthesis is stimulated by fat absorption, probably mediated by chylomicron formation. This stimulation of intestinal apo A-IV synthesis is attenuated by intravenous leptin infusion. Chronic ingestion of a high-fat diet blunts the intestinal apo A-IV in response to dietary lipid. Intestinal apo A-IV synthesis is also stimulated by members of the pancreatic polypeptide family, including peptide YY (PYY), neuropeptide Y (NPY), and pancreatic polypeptide (PP). Recently, apo A-IV was demonstrated to be present in the hypothalamus as well. Hypothalamic apo A-IV level was reduced by food deprivation and restored by lipid feeding. Intracerebroventricular administration of apo A-IV antiserum stimulated feeding and decreased the hypothalamic apo A-IV mRNA level, implying that feeding is intimately regulated by endogenous hypothalamic apo A-IV. Central administration of NPY significantly increased hypothalamic apo A-IV mRNA levels in a dose-dependent manner.
引用
下载
收藏
页码:1181 / 1189
页数:9
相关论文
共 50 条
  • [31] Inhibition of Vascular Inflammation by Apolipoprotein A-IV
    Shearston, Kate
    Tan, Joanne T. M.
    Cochran, Blake J.
    Rye, Kerry-Anne
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [32] Apolipoprotein A-IV inhibits experimental colitis
    Vowinkel, T
    Mori, M
    Krieglstein, CF
    Russell, J
    Saijo, F
    Bharwani, S
    Turnage, RH
    Davidson, WS
    Tso, P
    Granger, DN
    Kalogeris, TJ
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02): : 260 - 269
  • [33] Apolipoprotein A-IV enhances cholecystokinnin secretion
    Zhan, Jesse
    Weng, Jonathan
    Hunt, Brian G.
    Davidson, W. Sean
    Liu, Min
    Le, Chunmin C.
    PHYSIOLOGY & BEHAVIOR, 2018, 188 : 11 - 17
  • [34] Apolipoprotein A-IV Associated Cardiac Amyloidosis
    Bois, Melanie C.
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie
    Grogan, Martha
    Dispenzieri, Angela
    Kurtin, Paul J.
    Maleszewski, Joseph J.
    LABORATORY INVESTIGATION, 2016, 96 : 81A - 82A
  • [35] Apolipoprotein A-IV in the fed and fasting states
    Rafat, N
    Sattler, AM
    Hackler, R
    Soufi, M
    Steinmetz, A
    Maisch, B
    Schaefer, JR
    CLINICAL CHEMISTRY, 2004, 50 (07) : 1270 - 1271
  • [36] Gastrointestinal satiety signals - IV. Apolipoprotein A-IV
    Tso, P
    Sun, W
    Liu, M
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (06): : G885 - G890
  • [37] APOLIPOPROTEIN A-IV IN DIABETES-MELLITUS
    VERGES, B
    DIABETES & METABOLISM, 1995, 21 (02): : 99 - 105
  • [38] Severe experimental colitis in apolipoprotein A-IV knockout mice can be prevented with recombinant human apolipoprotein A-IV treatment
    Vowinkel, T
    Kalogeris, TJ
    Krieglstein, CF
    Mori, M
    Turnage, RH
    Tso, P
    Granger, DN
    GASTROENTEROLOGY, 2004, 126 (04) : A283 - A283
  • [39] PLASMA IGG AND APOLIPOPROTEIN A-IV (APO A-IV) LEVELS IN RATS FOLLOWING THE INJECTION OF ADJUVANT
    RODRIGUEZ, MD
    BOYKEN, VK
    WOLF, RE
    TSO, P
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 561 - 561
  • [40] Lymph and plasma release of intestinal apolipoprotein A-IV after gastric fat loading.
    RodriguezVaca, MD
    Kalogeris, T
    Wang, X
    Tso, P
    GASTROENTEROLOGY, 1996, 110 (04) : A834 - A834